doi:10.1016/j.eclinm.2024.102475 Manne-Goehler J, Teufel F, Venter WDF
This injectable medication belongs to a class called GLP-1 receptor agonists, which work by regulating appetite, slowing digestion, and helping control blood sugar levels
Since chronic inflammation can block GLP-1 receptors and disrupt gut hormone production, reducing it helps restore your bodys natural ability to produce and respond to GLP-1
Tp th dc u n: Gip tng cng tun hon mu, gip da hp thu dng cht tt hn
Even if GLP-1 increases, the downstream effects on appetite and weight depend on receptor sensitivity, metabolic rate, caloric intake, and dozens of other factors
Key discussion points should include your current Crohn's disease activity status, recent endoscopic or imaging findings, and nutritional assessment